|
|
|
|
| AP-1 |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| AP-1 Inhibitors |
1989 |
c-JUN peptide |
JNK/c-Jun interaction
inhibitor |
| 5309 |
SP 100030 |
NF-κB and AP-1 dual
inhibitor |
| 2476 |
SR 11302 |
AP-1 inhibitor;
antitumor agent |
| 7317 |
T 5224 |
Selective inhibitor
of c-Fos/activator protein (AP)-1 |
| |
|
|
|
| Aryl
Hydrocarbon Receptor |
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| Aryl Hydrocarbon Receptor Agonists |
6321 |
10-Cl-BBQ |
Potent
aryl hydrocarbon receptor (AhR) agonist; orally bioavailable |
| 5304 |
FICZ |
High
affinity aryl hydrocarbon receptor (AhR) agonist |
| 1803 |
ITE |
Endogenous
agonist for the transcription factor aryl hydrocarbon receptor |
| 3873 |
MeBIO |
AhR
agonist. Inactive analog of BIO (Cat. No. 3194) |
| 1267 |
Pifithrin-α
hydrobromide |
Aryl
hydrocarbon receptor agonist. Also p53 inhibitor |
| Aryl Hydrocarbon Receptor Antagonists |
3858 |
CH 223191 |
Potent
aryl hydrocarbon receptor (AhR) antagonist |
| 7086 |
StemRegenin 1 |
Aryl
hydrocarbon receptor (AhR) antagonist; promotes HSC expansion and engraftment |
| Ligands |
4393 |
L-Kynurenine |
Tryptophan
catabolite; endogenous aryl hydrocarbon receptor ligand |
| Other |
4995 |
Phortress |
Prodrug
of the antitumor agent 5F 203 |
| |
|
|
|
| Hypoxia
Inducible Factor |
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| Hypoxia Inducible Factor (HIF)
Inhibitors |
5953 |
Adaptaquin |
HIF-prolyl
hydroxylase-2 (PHD2) inhibitor; antioxidant |
| 5582 |
TAT-cyclo-CLLFVY |
Selective
HIF-1 dimerization inhibitor |
| 4408 |
DMOG |
Inhibitor
of hypoxia-inducible factor α (HIF-α) prolyl hydroxylase (HIF-PH) |
| 5520 |
Echinomycin |
Highly
potent and selective HIF-1α inhibitor |
| 6653 |
FM19G11 |
HIF
α-subunit inhibitor |
| 5655 |
GN 44028 |
Potent
HIF-1α inhibitor |
| 4451 |
IOX 2 |
Potent,
selective HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
| 4324 |
KC7F2 |
HIF-1α
inhibitor; down-regulates HIF-1α protein synthesis |
| 6322 |
LW 6 |
HIF-1α
inhibitor; inhibits cellular accumulation of HIF-1α; also malate
dehydrogenase-2 inhibitor |
| 2954 |
PX 12 |
Thioredoxin-1
inhibitor; attenuates expression of HIF-1α |
| 5243 |
TC-S 7009 |
High
affinity and selective HIF-2α inhibitor |
| 6156 |
VH 298 |
High-affinity
inhibitor of VHL; blocks interaction of VHL and HIF-α |
| Hypoxia Inducible Factor (HIF) Activators |
4565 |
ML 228 |
HIF
pathway activator |
| Other |
4705 |
Chetomin |
Blocks
interaction of HIF-1α, HIF-2α and STAT2 with CBP/p300 |
| 6157 |
cis VH 298 |
Negative
control for VH 298 |
| 5764 |
Deferoxamine mesylate |
Hypoxia
mimetic; also iron chelator |
| 7287 |
FAM-DEALA-Hyp-YIPD |
Fluorescent
HIF-1α peptide |
| 7452 |
FAM-DEALAHypYIPMDDDFQLRSF |
Fluorescent
HIF-1α peptide |
| |
|
|
|
| MYC |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| MYC Inhibitors |
4406 |
10058-F4 |
Inhibits c-Myc-Max
dimerization |
| 5306 |
KJ Pyr 9 |
High affinity Myc
inhibitor |
| |
|
|
|
| NF-κB
and IκB |
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| NF-κB and IκB Inhibitors |
4547 |
ACHP |
Selective
IKKα and IKKβ inhibitor; blocks NF-κB-DNA binding |
| 4857 |
Amlexanox |
Inhibitor
of TBK1 and IKKε; antiallergic agent |
| 1777 |
Arctigenin |
Inhibitor
of IκBα phosphorylation. Also inhibits MEK1 |
| 1743 |
Bay 11-7085 |
Irreversible
inhibitor of TNF-α-induced IκBα phosphorylation |
| 1744 |
Bay 11-7821 |
Indirect
inhibitor of IκBα phosphorylation |
| 5273 |
Bengamide B |
Potent
inhibitor of NF-κB activation |
| 5300 |
BI 605906 |
Selective
IKKβ inhibitor |
| 4806 |
BMS 345541 |
Selective
allosteric inhibitor of IKK; anti-inflammatory |
| 5821 |
C-DIM 12 |
Inhibits
NF-κB-dependent gene expression; Nurr1 activator |
| 2743 |
Caffeic acid
phenethyl ester |
Specific
inhibitor of NF-κB activation |
| 2509 |
Cardamonin |
Inhibitor
of NF-κB activation; anti-inflammatory |
| 6646 |
CDDO-Me |
NF-κB
pathway inhibitor; inhibits IKKβ; also Nrf2 pathway activator |
| 3203 |
Celastrol |
Inhibits
TNF-α-induced NF-κB activation |
| 6237 |
FPS ZM1 |
High
affinity antagonist of the receptor for advanced glycation end products
(RAGE) |
| 2637 |
Gliotoxin |
Immunosuppressant;
inhibits NF-κB and cytokine production |
| 5672 |
GSK 319347A |
Potent
and selective IKKε inhibitor |
| 4590 |
Honokiol |
Blocks
NF-κB activation; also anti-inflammatory and antioxidant |
| 2539 |
IKK 16 |
Selective
inhibitor of IKK |
| 2611 |
IMD 0354 |
Inhibitor
of IKKβ |
| 5699 |
IP7e |
Blocks
NF-κB pathway; also potent Nurr1 activator |
| 5846 |
IT 901 |
NF-κB
c-Rel subunit inhibitor |
| 2874 |
Luteolin |
Blocks
NF-κB activation |
| 1748 |
MG 132 |
Inhibits
NF-κB activation; proteasome and calpain inhibitor |
| 4899 |
ML 120B
dihydrochloride |
Novel
IKK2-selective inhibitor |
| 4354 |
ML 130 |
Inhibits
NOD1-induced NF-κB activation |
| 0610 |
Parthenolide |
NF-κB
inhibitor; also 5-HT release inhibitor |
| 4238 |
PF 184 |
Potent
and selective IKKβ inhibitor |
| 1554 |
Piceatannol |
Inhibits
TNF-induced NF-κB activation |
| 1947 |
PR 39 (porcine) |
IκBα
inhibitor |
| 3731 |
Pristimerin |
Suppresses
NF-κB activation |
| 4569 |
PS 1145
dihydrochloride |
Selective
IKK inhibitor; orally active |
| 0727 |
Pyrrolidinedithiocarbamate
ammonium |
Inhibits
NF-κB, prevents increase in NOS mRNA |
| 6259 |
RAGE antagonist
peptide |
Receptor
for advanced glycation end products (RAGE) antagonist |
| 3318 |
SC 514 |
IKKβ
inhibitor; attenuates NF-κB-induced gene expression |
| 6829 |
(R)-Shikonin |
Blocks
TNF-α and NF-κB signaling; induces necroptosis; anti-inflammatory |
| 5309 |
SP 100030 |
NF-κB
and AP-1 dual inhibitor |
| 4935 |
Sulfasalazine |
Inhibitor
of NF-κB activation; also inhibits SXC and folate transporter 1 |
| 4426 |
Tanshinone IIA |
Inhibits
NF-κB and AP-1 DNA binding. Displays antioxidant properties |
| 2559 |
TPCA-1 |
Potent,
selective inhibitor of IKKβ |
| 2816 |
Withaferin A |
Inhibits
NF-κB activation |
| 6111 |
Zoledronic Acid |
NF-κB
signaling inhibitor; also potent farnesyl diphosphate (FPP) synthase
inhibitor |
| NF-κB and IκB Activators |
3906 |
Betulinic acid |
Activates
NF-κB; antitumor and anti-HIV agent. Also TGR5 agonist |
| 6124 |
(R)-2-Hydroxyglutaric
acid disodium salt |
NF-κB
activator; also KDM4A inhibitor |
| 5739 |
Prostratin |
NF-κB
activator; also PKC activator |
| Other |
1126 |
Dexamethasone |
Reduces
levels of activated NF-κB in immature dendritic cells; anti-inflammatory
glucocorticoid |
| |
|
|
|
| NFAT |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| NFAT Inhibitors |
3930 |
NFAT Inhibitor |
Inhibitor
of calcineurin-mediated NFAT activation |
| 5710 |
NFAT inhibitor, Cell
Permeable |
Cell
permeable NFAT inhibitor |
| Other |
4210 |
Ascomycin |
Calcineurin
phosphatase inhibitor; analog of FK 506 (Cat. No. 3631) |
| 1101 |
Cyclosporin A |
Calcineurin
inhibitor |
| 3631 |
FK 506 |
Potent
calcineurin inhibitor; immunosuppressant |
| 2162 |
INCA-6 |
Inhibitor
of calcineurin-NFAT association |
| |
|
|
|
| Nrf2 |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| Nrf2 Inhibitors |
6243 |
ML 385 |
Nrf2
inhibitor; phenotypically lethal |
| Nrf2 Activators |
5145 |
AI-3 |
ARE
activator; induces Nrf2-ARE-dependent transcription |
| 4737 |
CDDO Im |
Nrf2
signaling activator |
| 6646 |
CDDO-Me |
Nrf2
pathway activator; also NF-κB pathway inhibitor; inhibits IKKβ |
| 4512 |
DMF |
Activator
of Nrf2 pathway; neuroprotective |
| 7199 |
(±)-Eriodictyol |
Activates
Nrf2/ARE signaling; antioxidant; also potent TRPV1 antagonist |
| 6172 |
INF 4E |
Activates
Keap1-Nrf2 pathway; also caspase-1 and NLRP3 inflammasome inhibitor |
| 5625 |
ML 334 |
Inhibitor
of Keap1- Nrf2 interaction |
| 4511 |
MMF |
Activator
of Nrf2 pathway; primary metabolite of DMF (Cat. No. 4512) |
| 5293 |
NK 252 |
Nrf2
activator |
| 6662 |
4-Octyl itaconate |
Nrf2
activator; cell permeable |
| 5294 |
Oltipraz |
Nrf2
activator |
| 5707 |
RA 839 |
Nrf2
activator; inhibits Nrf2/Keap1 interaction |
| 4811 |
TAT 14 |
Nrf2
pathway activator; blocks Nrf2/Keap1 interaction |
| |
|
|
|
| p53 |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| p53 Inhibitors |
1267 |
Pifithrin-α
hydrobromide |
p53
inhibitor. Also aryl hydrocarbon receptor agonist |
| 3843 |
Cyclic Pifithrin-α
hydrobromide |
p53
inhibitor |
| 2653 |
Pifithrin-μ |
Inhibitor
of p53-mitochondrial binding |
| p53 Activators |
3503 |
HLI 373 |
Hdm2
inhibitor; activates p53-dependent transcription |
| 6904 |
Idasanutlin |
Potent
MDM2 inhibitor; inhibits MDM2-p53 interaction |
| 6615 |
KCC 07 |
BAI1/p53
signaling activator; inhibits MBD2 (Methyl-CpG-binding domain protein 2) |
| 2185 |
NSC 146109
hydrochloride |
Cell-permeable,
genotype-selective antitumor agent; activates p53-dependent transcription |
| 5065 |
NSC 319726 |
Reactivator
of mutant p53 |
| 3984 |
Nutlin-3 |
MDM2
antagonist; inhibits MDM2-p53 interaction |
| 6075 |
Nutlin 3a |
MDM2
antagonist; active enantiomer of Nutlin-3 (Cat. No. 3984) |
| 2443 |
RITA |
p53-MDM2
interaction inhibitor; antitumor |
| 5332 |
SP 141 |
High
affinity MDM2 inhibitor |
| 3365 |
Tenovin-1 |
Activates
p53 transcriptional activity |
| 3356 |
WR 1065
dihydrochloride |
p53
activator. Also ROS scavenger |
| Other |
5417 |
BMH 21 |
p53
pathway activator; also RNA polymerase 1 inhibitor |
| 3362 |
MIRA-1 |
Restores
mutant p53 activity; proapoptotic |
| 4326 |
PhiKan 083 |
p53
stabilizing agent |
| 4396 |
Piperlongumine |
Induces
apoptosis; increases p53 and ROS levels in cancer cells |
| 1862 |
PRIMA-1 |
Restores
mutant p53 activity; induces apoptosis |
| 3710 |
PRIMA-1MET |
Restores
mutant p53 activity |
| 3214 |
RETRA hydrochloride |
Antitumor
agent; suppresses mutant p53-bearing cancer cells |
| 4240 |
SCH 529074 |
Restores
mutant p53 activity |
| |
|
|
|
| SREBP |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| SREBP Inhibitors |
4444 |
Fatostatin A |
Cell
permeable inhibitor of SREBP activation |
| 3354 |
PF 429242
dihydrochloride |
Competitive
inhibitor of SREBP site 1 protease |
| |
|
|
|
| STAT |
|
|
|
| |
|
|
|
| |
Cat. No. |
Product Name |
Activity |
| STAT Inhibitors |
1571 |
Cucurbitacin I |
Selective
inhibitor of STAT3/JAK2 signaling |
| 6218 |
Galiellalactone |
STAT3
inhibitor; active in vivo |
| 6110 |
HJC 0416
hydrochloride |
STAT3
inhibitor |
| 5522 |
Napabucasin |
STAT3
inhibitor; also blocks cancer stem cell self-renewal |
| 4079 |
Niclosamide |
STAT3
inhibitor; also inhibits mTORC1 signaling |
| 4655 |
NSC 74859 |
Selective
STAT3 inhibitor |
| 3918 |
Pyrimethamine |
STAT3
inhibitor; also potent inhibitor of multidrug and toxin extrusion (MATE)
transporters and DHFR inhibitor |
| 5138 |
RSVA 405 |
STAT3
inhibitor; also AMPK activator |
| 3035 |
SD 1008 |
JAK2/STAT3
signaling pathway inhibitor |
| 2798 |
Stattic |
Selective
STAT3 inhibitor |
| STAT Activators |
3945 |
Colivelin |
STAT3
activator; also protects against β-amyloid neurotoxicity |
| Other |
3495 |
Fludarabine |
Purine
analog; inhibits cytokine-induced STAT1 activation |
| 6994 |
HODHBt |
STAT5-SUMO
protein-protein interaction inhibitor |